PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur — 6 ampoule(s) polyéthylène de 2,5 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400936467484
  • CIP7 3646748
  • CIS 60866491

What the source publishes

Holder
ROCHE
Active ingredients
DÉSOXYRIBONUCLÉASE
Form
solution pour inhalation par nébuliseur
Package
6 ampoule(s) polyéthylène de 2,5 ml
Routes
inhalée
Administrative status
authorised
Supply regime
prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
1994-03-10
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400936467484
{
  "cis": "60866491",
  "cip7": "3646748",
  "form": "solution pour inhalation par nébuliseur",
  "name": "PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur — 6 ampoule(s) polyéthylène de 2,5 ml",
  "cip13": "3400936467484",
  "holder": "ROCHE",
  "routes": [
    "inhalée"
  ],
  "holders": [
    "ROCHE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "163.93",
  "authorisedOn": "1994-03-10",
  "compositions": [
    {
      "name": "DÉSOXYRIBONUCLÉASE",
      "nature": "SA",
      "strength": "2500 U (2,5 mg)",
      "linkageNumber": "1",
      "substanceCode": "05291",
      "dosageReference": "2,5 ml",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "162.91",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "6 ampoule(s) polyéthylène de 2,5 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2005-09-12",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DÉSOXYRIBONUCLÉASE"
  ],
  "authorisationProcedure": "Procédure de reconnaissance mutuelle",
  "prescriptionConditions": [
    "prescription initiale hospitalière semestrielle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400936467484"